Nuclear Imaging in Drug Discovery, Development, and Approval
Latest Publications

TOTAL DOCUMENTS

17

(FIVE YEARS 0)

H-INDEX

2

(FIVE YEARS 0)

Published By Birkhäuser Boston

9781468468106, 9781468468083

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Cerebral Metabolic Rates of 2-[18F]Fluoro-2-Deoxy-D-Glucose in the Presence of Ofloxacin A GABAA Receptor Antagonist

Nuclear Imaging in Drug Discovery, Development, and Approval ◽

10.1007/978-1-4684-6808-3_9 ◽

1993 ◽

pp. 167-177

Author(s):

Edwaldo E. Camargo ◽

Zsolt Szabo ◽

Robert F. Dannals ◽

Henry N. Wagner

Keyword(s):

Receptor Antagonist ◽

Gabaa Receptor ◽

Metabolic Rates ◽

Gabaa Receptor Antagonist

Download Full-text

Quantitative Whole Body Autoradiographic Microimaging for Pharmaceutical Research

Nuclear Imaging in Drug Discovery, Development, and Approval ◽

10.1007/978-1-4684-6808-3_8 ◽

1993 ◽

pp. 149-166

Author(s):

Prantika Som ◽

Zvi H. Oster

Keyword(s):

Pharmaceutical Research ◽

Download Full-text

Applications of Autoradiography to Drug Discovery

Nuclear Imaging in Drug Discovery, Development, and Approval ◽

10.1007/978-1-4684-6808-3_7 ◽

1993 ◽

pp. 135-148

Author(s):

Raymond E. Gibson ◽

Holly T. Beauchamp ◽

Susan Iversen ◽

Barry Everitt ◽

James McCulloch ◽

...

Keyword(s):

Download Full-text

Nuclear Medicine Physics, Instrumentation, and Data Processing in Pharmaceutical Research

Nuclear Imaging in Drug Discovery, Development, and Approval ◽

10.1007/978-1-4684-6808-3_2 ◽

1993 ◽

pp. 11-31

Author(s):

Jonathan M. Links

Keyword(s):

Nuclear Medicine ◽

Data Processing ◽

Pharmaceutical Research

Download Full-text

Iodinated Dopamine D1 and D2 Receptor Imaging Agents for SPECT

Nuclear Imaging in Drug Discovery, Development, and Approval ◽

10.1007/978-1-4684-6808-3_12 ◽

1993 ◽

pp. 227-243

Author(s):

Hank F. Kung

Keyword(s):

D2 Receptor ◽

Imaging Agents ◽

Receptor Imaging

Download Full-text

Chemistry of Tracers for Positron Emission Tomography

Nuclear Imaging in Drug Discovery, Development, and Approval ◽

10.1007/978-1-4684-6808-3_4 ◽

1993 ◽

pp. 55-74

Author(s):

Robert F. Dannals ◽

Hayden T. Ravert ◽

Alan A. Wilson

Keyword(s):

Positron Emission Tomography ◽

Emission Tomography ◽

Positron Emission

Download Full-text

The Gastrointestinal Transit and Systemic Absorption of Diltiazem HCL from a Modified Release Dosage Form

Nuclear Imaging in Drug Discovery, Development, and Approval ◽

10.1007/978-1-4684-6808-3_16 ◽

1993 ◽

pp. 301-320

Author(s):

Donald L. Heald ◽

John A. Ziemniak ◽

Ian R. Wilding

Keyword(s):

Dosage Form ◽

Gastrointestinal Transit ◽

Systemic Absorption ◽

Modified Release ◽

Download Full-text

The Role of Positron Emission Tomography in Assessing and Monitoring Dopamine Active Drugs

Nuclear Imaging in Drug Discovery, Development, and Approval ◽

10.1007/978-1-4684-6808-3_11 ◽

1993 ◽

pp. 201-225

Author(s):

Dean F. Wong ◽

Babington Yung

Keyword(s):

Positron Emission Tomography ◽

Emission Tomography ◽

Positron Emission

Download Full-text

Positron Emission Tomography, Enzymes and Drug Research and Development

Nuclear Imaging in Drug Discovery, Development, and Approval ◽

10.1007/978-1-4684-6808-3_10 ◽

1993 ◽

pp. 179-200

Author(s):

Joanna S. Fowler ◽

Nora D. Volkow ◽

Alfred P. Wolf

Keyword(s):

Positron Emission Tomography ◽

Research And Development ◽

Drug Research ◽

Emission Tomography ◽

Positron Emission

Download Full-text

The Design of Site-Directed Radiopharmaceuticals for Use in Drug Discovery

Nuclear Imaging in Drug Discovery, Development, and Approval ◽

10.1007/978-1-4684-6808-3_6 ◽

1993 ◽

pp. 113-134 ◽

Author(s):

William C. Eckelman ◽

Raymond E. Gibson

Keyword(s):

Download Full-text